Medifast (MED) Competitors $13.98 +0.06 (+0.42%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$13.96 -0.02 (-0.14%) As of 09/12/2025 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MED vs. LW, NOMD, USNA, NUS, NATR, VERU, EL, IPAR, PBH, and HLFShould you be buying Medifast stock or one of its competitors? The main competitors of Medifast include Lamb Weston (LW), Nomad Foods (NOMD), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Veru (VERU), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), and Herbalife (HLF). Medifast vs. Its Competitors Lamb Weston Nomad Foods USANA Health Sciences Nu Skin Enterprises Nature's Sunshine Products Veru Estee Lauder Companies Interparfums Prestige Consumer Healthcare Herbalife Lamb Weston (NYSE:LW) and Medifast (NYSE:MED) are both consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends. Do analysts rate LW or MED? Lamb Weston currently has a consensus price target of $65.30, indicating a potential upside of 15.56%. Medifast has a consensus price target of $16.50, indicating a potential upside of 18.03%. Given Medifast's higher probable upside, analysts plainly believe Medifast is more favorable than Lamb Weston.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lamb Weston 0 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.30Medifast 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better earnings and valuation, LW or MED? Lamb Weston has higher revenue and earnings than Medifast. Lamb Weston is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLamb Weston$6.45B1.22$357.20M$2.5122.51Medifast$602.46M0.26$2.09M$0.3243.68 Does the media favor LW or MED? In the previous week, Lamb Weston had 7 more articles in the media than Medifast. MarketBeat recorded 9 mentions for Lamb Weston and 2 mentions for Medifast. Medifast's average media sentiment score of 1.70 beat Lamb Weston's score of 1.37 indicating that Medifast is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lamb Weston 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medifast 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is LW or MED more profitable? Lamb Weston has a net margin of 5.54% compared to Medifast's net margin of 0.76%. Lamb Weston's return on equity of 27.99% beat Medifast's return on equity.Company Net Margins Return on Equity Return on Assets Lamb Weston5.54% 27.99% 6.43% Medifast 0.76%2.00%1.50% Which has more risk and volatility, LW or MED? Lamb Weston has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, Medifast has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Do institutionals & insiders have more ownership in LW or MED? 89.6% of Lamb Weston shares are owned by institutional investors. Comparatively, 95.5% of Medifast shares are owned by institutional investors. 0.3% of Lamb Weston shares are owned by company insiders. Comparatively, 2.9% of Medifast shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryLamb Weston beats Medifast on 10 of the 16 factors compared between the two stocks. Get Medifast News Delivered to You Automatically Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MED vs. The Competition Export to ExcelMetricMedifastFOOD IndustryStaples SectorNYSE ExchangeMarket Cap$153M$8.30B$16.01B$21.58BDividend YieldN/A3.37%3.01%3.48%P/E Ratio43.6922.2118.2729.75Price / Sales0.261.8347.0086.27Price / Cash4.7412.9614.9525.00Price / Book0.733.806.134.58Net Income$2.09M$402.24M$679.99M$999.94M7 Day Performance3.20%0.79%1.12%0.68%1 Month Performance2.04%-1.60%-0.22%3.10%1 Year Performance-26.00%-4.72%5.80%14.39% Medifast Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDMedifast4.0156 of 5 stars$13.98+0.4%$16.50+18.0%-25.4%$153M$602.46M43.69870Positive NewsLWLamb Weston4.7652 of 5 stars$57.53-0.8%$65.30+13.5%-11.5%$8.08B$6.45B22.9210,100News CoveragePositive NewsNOMDNomad Foods4.8022 of 5 stars$14.53-1.2%$20.33+39.9%-26.1%$2.26B$3.35B9.957,788Short Interest ↓USNAUSANA Health Sciences4.0053 of 5 stars$30.90-2.9%$36.00+16.5%-19.8%$581.41M$854.50M17.171,700Positive NewsNUSNu Skin Enterprises3.6204 of 5 stars$11.53+0.3%$6.88-40.3%+59.2%$568.73M$1.73B5.733,100NATRNature's Sunshine Products3.6243 of 5 stars$17.14flat$19.67+14.7%+28.0%$302.27M$454.36M23.16850VERUVeru2.5223 of 5 stars$3.37flat$33.33+889.1%-58.7%$49.40M$16.89M-1.53230ELEstee Lauder Companies4.2296 of 5 stars$88.83-0.4%$87.80-1.2%-0.5%$32.10B$14.33B-28.2957,000Trending NewsAnalyst RevisionIPARInterparfums4.4002 of 5 stars$113.73+0.6%$162.00+42.4%-7.8%$3.63B$1.46B22.79530News CoveragePositive NewsPBHPrestige Consumer Healthcare4.3369 of 5 stars$65.68+1.0%$93.33+42.1%-13.3%$3.20B$1.14B15.42540HLFHerbalife4.2373 of 5 stars$9.85-0.1%$11.50+16.7%+31.1%$1.02B$4.99B3.118,600Positive News Related Companies and Tools Related Companies LW Competitors NOMD Competitors USNA Competitors NUS Competitors NATR Competitors VERU Competitors EL Competitors IPAR Competitors PBH Competitors HLF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MED) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
